22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash RequirementsBUFFALO, N.Y., Nov. 27, 2023 (GLOBE…
Pharmaceuticals, Biotechnology and Life Sciences
Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash RequirementsBUFFALO, N.Y., Nov. 27, 2023 (GLOBE…
NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
FLORHAM PARK, N.J., Nov. 24, 2023 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (the “Company”), a biotechnology company developing allogeneic…
TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical…
TORONTO and HAIFA, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company”…
LONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) — Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access…
DURHAM, N.C., Nov. 24, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable,…
World AMR Awareness Week campaign looks to provide understanding of AMR and to promote best practices among all industry stakeholders…
Honor awarded last night recognizes Theratechnologies and Prof. Borhane Annabi for advancing preclinical development of sudocetaxel zendusortide for treatment of…
DURHAM, N.C., Nov. 24, 2023 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), today announced that on November 20, 2023, the Compensation Committee…